Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. E Vuori,
  2. J Lonnqvist,
  3. T Klaukka
  1. University of Helsinki, Department of Forensic Medicine, PO Box 40 (Kytosuontie 11), FIN 00014
  2. University of Helsinki, Finland National Public Health Institute, Department of Mental Health, FIN 00300
  3. Helsinki Social Insurance Institution of Finland, PO Box 78, FIN 00381 Helsinki.

    EDITOR, - Goran Isacsson and colleagues examined the use of various antidepressants among people who committed suicide and concluded that therapeutic failure may be a greater problem than toxicity.1 They state that they refrained from ranking different drugs, but this occurred in practice because the differences found were explained on the grounds of the weaker antidepressive effect of the newer drugs, moclobemide and mianserin. The basis for the authors' conclusion was that, despite their relatively low toxicity, both drugs were overrepresented in the people who had committed suicide compared with their use in general.

    The rate of suicide in Finland …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular